Dimensional Fund Advisors’s Tenax Therapeutics TENX Stock Holding History

Dimensional Fund Advisors’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.69M	Buy	253,518 +190,732	+304%	+$2.44M	﹤0.01%	2608
2026 Q1	$1M	Buy	+62,786	New	+$849K	﹤0.01%	2843
2025 Q3	–	Sell	-15,930	Closed	-$93K	–	3344
2025 Q2	$93K	Sell	15,930 -3,313	-17%	-$19.1K	﹤0.01%	3186
2025 Q1	$126K	Sell	19,243 -1,763	-8%	-$11.3K	﹤0.01%	3178
2024 Q4	$130K	Hold	21,006	–	–	﹤0.01%	3213
2024 Q3	$72.7K	Buy	+21,006	New	+$76.1K	﹤0.01%	3264
2021 Q3	–	Sell	-32	Closed	-$113K	–	3532
2021 Q2	$113K	Sell	32 -6	-16%	-$19K	﹤0.01%	3400
2021 Q1	$115K	Buy	+38	New	+$136K	﹤0.01%	3340
2018 Q4	–	Sell	-9	Closed	-$77K	–	3459
2018 Q3	$77K	Hold	9	–	–	﹤0.01%	3375
2018 Q2	$93K	Hold	9	–	–	﹤0.01%	3307
2018 Q1	$80K	Buy	+9	New	+$104K	﹤0.01%	3296
2017 Q1	–	Sell	-1	Closed	-$73K	–	3310
2016 Q4	$73K	Hold	1	–	–	﹤0.01%	3259
2016 Q3	$92K	Hold	1	–	–	﹤0.01%	3235
2016 Q2	$103K	Hold	1	–	–	﹤0.01%	3233
2016 Q1	$82K	Hold	1	–	–	﹤0.01%	3241
2015 Q4	$132K	Hold	1	–	–	﹤0.01%	3250
2015 Q3	$59K	Buy	+1	New	+$114K	﹤0.01%	3331

Other funds holding TENX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Dimensional Fund Advisors's TENX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Tenax Therapeutics (TENX) stake by 304% in Q2 2026, buying an estimated $2.44M and bringing the position to 253,518 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Dimensional Fund Advisors first reported a position in TENX in Q3 2015 and has held it in 17 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

Dimensional Fund Advisors held 253,518 shares of Tenax Therapeutics worth $3.69M as of Q2 2026.
Dimensional Fund Advisors bought 190,732 Tenax Therapeutics shares in Q2 2026, an estimated $2.44M.
Tenax Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2608 holding.
Dimensional Fund Advisors first reported a position in Tenax Therapeutics in Q3 2015 and has held it in 17 quarters since.
111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.